Lou Basenese's most recent trade in ClearSign Technologies Corp was a trade of 34,722 Restricted Stock Units done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ClearSign Technologies Corp | Lou Basenese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 34,722 | 45,645 | - | - | Restricted Stock Units | |
| ENDRA Life Sciences Inc | Lou Basenese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 5,384 | 5,385 | - | 0 | Common Stock | |
| ClearSign Technologies Corp | Lou Basenese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 10,923 | 10,923 | - | - | Restricted Stock Units | |
| ENDRA Life Sciences Inc | Basenese Lou | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 600 | 600 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Lou Basenese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 6,746 | 6,746 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Lou Basenese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 74,500 | 74,500 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Lou Basenese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 12,000 | 12,000 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Lou Basenese | Director | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 25 Aug 2021 | 45,000 | 54,068 | - | 1.8 | 82,350 | Common Stock |
| ENDRA Life Sciences Inc | Lou Basenese | Director | Sale of securities on an exchange or to another person at price $ 1.85 per share. | 25 Aug 2021 | 5,000 | 49,068 | - | 1.9 | 9,250 | Common Stock |
| ENDRA Life Sciences Inc | Lou Basenese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 25,000 | 25,000 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Lou Basenese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 12,000 | 12,000 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Lou Basenese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2020 | 50,000 | 50,000 | - | - | Stock Option (right to buy) |